Cargando…
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study
Background: Protease inhibitors have been considered as possible therapeutic agents for COVID-19 patients. Objectives: To describe the association between lopinavir/ritonavir (LPV/r) or darunavir/cobicistat (DRV/c) use and in-hospital mortality in COVID-19 patients. Study Design: Multicenter observa...
Ejemplares similares
-
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study
por: Di Castelnuovo, Augusto, et al.
Publicado: (2020) -
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering
por: Di Castelnuovo, Augusto, et al.
Publicado: (2021) -
Information disorders during the COVID-19 infodemic: The case of Italian Facebook
por: Guarino, Stefano, et al.
Publicado: (2021) -
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia
por: Dell’Acqua, Raffaele, et al.
Publicado: (2017) -
Pathways of care for HIV infected children in Beira, Mozambique: pre-post intervention study to assess impact of task shifting
por: Marotta, Claudia, et al.
Publicado: (2018)